Select Page

Basic Female Cancer Markers Test

  1. Home
  2. Departments
  3. Basic Female Cancer Markers Test

Emergency Cases

Delivering fast and accurate test results when you need them most.

 

Call +962790797901

Opening Hours

Saturday - Thursday
8:00am - 10:00pm
Friday
Closed

Basic Female Cancer Markers Test

Early detection can significantly improve the treatment and management of cancer. The Basic Female Cancer Markers Test from T-lab is designed to screen for key cancer markers in women, focusing on the early detection of common cancers that affect the female body. This test provides an essential tool for proactive health management and peace of mind.

Duration: 1 Day
Special Requirements: Fasting for 10-12 hours may be required depending on your physician’s recommendation.

Profile Includes:

General Tests:

  • Complete Blood Count (CBC): Assesses overall health and detects conditions like anemia, infections, and blood cancers.
  • Fasting Blood Sugar (Glucose): Screens for diabetes, which may be linked to certain cancers or affect cancer treatment outcomes.

Cancer Marker Tests:

  • CA-125 (Cancer Antigen 125): This is a key marker for ovarian cancer, where elevated levels can indicate the presence of cancerous growths.
  • Carcinoembryonic Antigen (CEA): Useful for detecting cancers such as breast, colon, and ovarian. Elevated levels of CEA suggest the need for further investigation.
  • Alpha-Fetoprotein (AFP): While primarily used in liver cancer detection, AFP is also useful for certain ovarian cancers.
  • BRCA1/BRCA2 Gene Mutation (if applicable): Genetic screening for these mutations can help assess the risk of breast and ovarian cancers.

Breast Cancer Screening:

  • Cancer Antigen 15-3 (CA 15-3): Primarily used to monitor breast cancer recurrence and treatment effectiveness, elevated levels may indicate the need for additional imaging or testing.

Liver Function Tests:

  • Alanine Aminotransferase (ALT/GPT): Monitors liver health, as liver function may be impacted by metastatic cancer or cancer treatments.
  • Aspartate Aminotransferase (AST/GOT): Another key marker for liver function, crucial when tracking cancer progression or liver metastasis.

Additional Screening:

  • C-Reactive Protein (CRP): Detects inflammation in the body, which can be linked to cancer progression or response to treatment.
  • Lactate Dehydrogenase (LDH): Measures tissue damage and is often elevated in the presence of cancer or aggressive cancer treatments.
×